Stock Ratings | HC Wainwright raised its price target for Q32 Bio (QTTB) to $36, representing a potential upside of 129.15%; Bank of Montreal raised its price target for Amazon (AMZN) to $360.
Q32 Bio Inc QTTB | 0.00 | |
ProMIS Neurosciences Inc. PMN | 0.00 | |
Matador Resources Company MTDR | 0.00 | |
Tenax Therapeutics, Inc. TENX | 0.00 | |
MapLight Therapeutics, Inc. MPLT | 0.00 |
The ratings of major US investment banks are used to track the latest valuations and target prices on Wall Street daily, and to explore potential equity investment opportunities.
Risk warning:
Investing in small-cap stocks can be risky. Be prepared for potential challenges related to liquidity, high volatility, limited information, and financial instability. Always diversify your investments.
Today's key assessments and concerns
HC Wainwright & Co.: Maintaining a "buy" rating on Q32 Bio ( Q32 Bio Inc(QTTB.US) ), while raising the price target from $13 to $36.
Chardan Capital: Maintaining a "buy" rating on ProMIS Neurosciences ( ProMIS Neurosciences Inc.(PMN.US) ), while raising the price target from $20 to $33.
Stephens & Co.: Maintaining an "overweight" rating on Matador Resources ( Matador Resources Company(MTDR.US) ), while raising the price target from $92 to $93.
Canaccord Genuity: Initial rating for Tenax Therapeutics ( Tenax Therapeutics, Inc.(TENX.US) ) stock at "Buy", with a target price of $35.
HC Wainwright & Co.: Maintaining a "buy" rating on MapLight Therapeutics ( MapLight Therapeutics, Inc.(MPLT.US) ), while lowering the price target from $45 to $26.
| The symbol | Classification | Target price | Current price | Percentage of potential increase/decrease | (Classification) Agency |
| Q32 Bio Inc(QTTB.US) | to lift | $36.0 | $15.71 | 129.15% | HC Wainwright & Co. |
| ProMIS Neurosciences Inc.(PMN.US) | to lift | $33.0 | $14.52 | 127.27% | Chardan Capital |
| Matador Resources Company(MTDR.US) | to lift | $93.0 | $46.12 | 101.65% | Stephens & Co. |
| Cleanspark, Inc.(CLSK.US) | to lift | $25.0 | $13.48 | 85.46% | Keefe, Bruyette & Woods |
| NRG Energy, Inc.(NRG.US) | to lift | $204.0 | $127.56 | 59.92% | Barclays |
| Tenax Therapeutics, Inc.(TENX.US) | Initial classification | $35.0 | $15.8 | 121.52% | Canaccord Genuity |
| MapLight Therapeutics, Inc.(MPLT.US) | cut | $26.0 | $12.31 | 111.21% | HC Wainwright & Co. |
| MapLight Therapeutics, Inc.(MPLT.US) | cut | $24.0 | $12.31 | 94.96% | Canaccord Genuity |
| Rambus Inc.(RMBS.US) | cut | $160.0 | $87.75 | 82.34% | Evercore ISI Group |
| Lithium Argentina AG(LAR.US) | cut | $10.0 | $5.61 | 78.25% | Scotiabank |
comments:
Target price unit and current price: US Dollar;
Current price: As of the latest closing price of US stocks;
Potential percentage increase/potential decrease = (Agency target price - current price) / current price 100% (Current price = Last closing price up to the time of the count)
Lifting
BMO Capital: Maintaining its "outperform" rating for Amazon ( Amazon.com, Inc.(AMZN.US) ), while raising its price target from $355 to $360.
Citigroup: Maintaining a "buy" rating on Datadog ( Datadog(DDOG.US) ) stock, while raising the price target from $270 to $300.
B of A Securities: Upgrades Honeywell ( Honeywell International Inc.(HON.US) ) to "Neutral", raising the price target from $205 to $265.
BTIG: Maintaining a "buy" rating on Twilio Twilio(TWLO.US) ) stock, while raising the price target from $215 to $245.
First Coverage
Loop Capital: Initial rating on CrowdStrike Holdings CrowdStrike(CRWD.US) ) stock at "Buy", with a target price of $230.
UBS: Inspire Medical Systems ( Inspire Medical Systems, Inc.(INSP.US) ) has a preliminary "Sell" rating on its stock, with a target price of $39.
UBS: Steris ( STERIS plc(STE.US) ) stock has a preliminary rating of "buy", with a target price of $275.
reduction
UBS: Maintaining a "buy" rating on Amazon ( Amazon.com, Inc.(AMZN.US) ) stock, while lowering its price target from $333 to $305.
JP Morgan: Maintaining an "overweight" rating on Trip.com ( Trip.com International Ltd Sponsored ADR(TCOM.US) ), while lowering its price target from $75 to $72.
B of A Securities: Downgraded ExxonMobil Exxonmobil Holdings Corporation(XOM.US) ) rating to "neutral", while raising the price target from $154 to $158.
Editor's Note: This content was created by Saham's AI-powered SaaS tool and reviewed by our editorial team.
Risk Warning: Investing involves risk. Securities may rise, fall, or become worthless. Investing does not guarantee profits and may result in losses. Past performance is not necessarily indicative of future results. Before making any investment decision, investors should assess their financial situation, investment objectives, experience, risk tolerance, and understand the nature of the investment products and their associated risks. For more details on the nature and risks of each investment product, please read the relevant offering documents carefully. If you have any questions, it is advisable to seek independent professional advice.